Department of Department of Cognitive, Linguistic, and Psychological Sciences, Brown University, Providence, Rhode Island.
Department of Psychological & Brain Sciences, Washington University in St. Louis, St. Louis, Missouri; Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri; Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri.
Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Oct;7(10):1035-1046. doi: 10.1016/j.bpsc.2021.03.017. Epub 2021 Apr 18.
Psychiatric diagnosis and treatment have historically taken a symptom-based approach, with less attention on identifying underlying symptom-producing mechanisms. Recent efforts have illuminated the extent to which different underlying circuitry can produce phenotypically similar symptomatology (e.g., psychosis in bipolar disorder vs. schizophrenia). Computational modeling makes it possible to identify and mathematically differentiate behaviorally unobservable, specific reinforcement learning differences in patients with schizophrenia versus other disorders, likely owing to a higher reliance on prediction error-driven learning associated with basal ganglia and underreliance on explicit value representations associated with orbitofrontal cortex.
We used a well-established probabilistic reinforcement learning task to replicate those findings in individuals with schizophrenia both on (n = 120) and off (n = 44) antipsychotic medications and included a patient comparison group of bipolar patients with psychosis (n = 60) and healthy control subjects (n = 72).
Using accuracy, there was a main effect of group (F = 7.87, p < .001), such that all patient groups were less accurate than control subjects. Using computationally derived parameters, both medicated and unmediated individuals with schizophrenia, but not patients with bipolar disorder, demonstrated a reduced mixing parameter (F = 13.91, p < .001), indicating less dependence on learning explicit value representations as well as greater learning decay between training and test (F = 12.81, p < .001). Unmedicated patients with schizophrenia also showed greater decision noise (F = 2.67, p = .04).
Both medicated and unmedicated patients showed overreliance on prediction error-driven learning as well as significantly higher noise and value-related memory decay, compared with the healthy control subjects and the patients with bipolar disorder. Additionally, the computational model parameters capturing these processes can significantly improve patient/control classification, potentially providing useful diagnosis insight.
精神科诊断和治疗历来采用基于症状的方法,较少关注识别潜在的症状产生机制。最近的研究表明,不同的潜在电路可以产生表型相似的症状(例如,双相情感障碍与精神分裂症中的精神病)。计算建模使得有可能识别和数学区分精神分裂症患者与其他疾病患者的行为上不可观察的、特定的强化学习差异,这可能是由于与基底神经节相关的更高的依赖于预测误差驱动的学习以及对与眶额皮层相关的明确价值表示的依赖不足。
我们使用一种成熟的概率强化学习任务,在服用(n=120)和未服用(n=44)抗精神病药物的精神分裂症患者中复制这些发现,并包括一组有精神病的双相情感障碍患者(n=60)和健康对照组(n=72)作为患者比较组。
使用准确性,存在组间的主要效应(F=7.87,p<.001),即所有患者组的准确性均低于对照组。使用计算得出的参数,服用药物和未服用药物的精神分裂症患者均表现出混合参数降低(F=13.91,p<.001),表明对学习明确价值表示的依赖性降低,以及在训练和测试之间的学习衰减更大(F=12.81,p<.001)。未服用药物的精神分裂症患者还表现出更大的决策噪声(F=2.67,p=.04)。
与健康对照组和双相情感障碍患者相比,服用药物和未服用药物的患者均表现出对预测误差驱动学习的过度依赖,以及明显更高的噪声和与价值相关的记忆衰减。此外,捕获这些过程的计算模型参数可以显著改善患者/对照分类,为提供有用的诊断见解提供了可能性。